CONNECTED DEVELOPMENT
TO PRODUCTION,
BETTER QUALITY
An integrated development process connecting planning to production,
delivering superior product quality and manufacturing stability.
R&D process

StructuredDevelopment Process
A step-by-step development framework from global trend analysis to raw material validation and testing.
TREND ANTICIPATION
Trend Anticipation
Global research data insights
Next-generation market trend forecasting
Identifying optimal development timing for brand strategy

GLOBAL STANDARD DEVELOPMENT
Global Standard Formulation Design
Formulation design reflecting each country's regulatory environment
Optimization by climate and lifestyle conditions
Prescription design tailored to individual brand strategies

MATERIAL & INGREDIENT VALIDATION
Material & Ingredient Pre-validation
Review of global-standard ingredient data
Ingredient selection focused on efficacy and stability
Securing regulatory-compliant material options by market

PILOT & PRE-PRODUCTION TESTING
Pilot & Pre-production Testing
Formulation validation through pilot-scale production
Pre-confirmation of process suitability
Validation to minimize mass-production risk

Quality ControlGate System
Every product passes through 4 quality control gates — from raw materials to shipment.

GATE 1
Pre-intake Inspection
Full COA review of incoming materials / In-house physicochemical testing / Full return of below-standard materials / Supplier grade management integration

GATE 2
Post-compounding Inspection
Full check of viscosity, pH, and appearance after compounding / Immediate re-compounding if specification deviation exceeds ±5% / Automated MES recording

GATE 3
Post-filling & Packaging Inspection
Microbial limit testing, safety, and full label verification. AQL-based sampling achieves inspection reliability equivalent to 100% testing.

GATE 4
Pre-shipment Inspection
Final specification re-verification + complete LOT traceability records. Shipment halted immediately upon any anomaly. Entire process automatically recorded and retained in MES.
15 YEARSOF BUILDING
From 2009 to the present — the trajectory of R&D at ANCORS.
2024–2023
2024
228 IP rights, 80 researchers, 114 patents
IP
2023
Korea Beauty Industry Award — Innovation Manufacturer, KRW 117B revenue achieved
Award
2022–2020
2022
Regulatory & licensing lab established; FDA, EU & NMPA frameworks built
Global
2020
70+ patents surpassed; Smart Factory R&D integration
IP
2018–2015
2018
ISO 22716 certified; concentrated sun care patent acquisition
Cert.
2015
30+ researchers reached; 20 cumulative patents
Growth
2012–2009
2012
First hydrogel mask formulation patent acquired
IP
2009
Corporation founded & R&D center established
Founded
YOUR BEAUTY,OUR MISSION.
© 2026 ANCORS Co., Ltd.. All rights reserved.